This Consortium serves as the review committee for the Diversity Supplement Program. Below is a list of the current members.
Name | Area(s) of Expertise | Phone |
---|---|---|
Pamela Goodlow (Chair) |
Ethnic/minority issues, research training and career development |
301-435-0925 |
Drug abuse treatment research, treatment research in community settings, treatment of pain |
301-443-3207 |
|
Ethnic populations (Hispanic/Latino and Asian American and Pacific Islander) |
301-443-0441 |
|
Grant management issues |
202-722-4093 |
|
Pharmacology; neuroscience; AIDS |
301-402-1972 |
|
Neuroplasticity and neurotoxicology; methamphetamine; marijuana; hallucinogens |
301-435-1312 |
|
Treatment and Intervention Services for HIV/AIDS; gender differences; co-occurring disorders |
301-402-1984 |
|
Medical consequences of drug abuse and co-occurring infections; clinical molecular biology; immunology; neuroscience |
301-443-1061 |
|
Prenatal/perinatal exposure; maternal/fetal pharmacokinetics; pain/analgesia; physiological systems |
301-594-5753 |
|
Prevention; early interventions; preadolescent and adolescent drug abuse and HIV prevention; methodology research |
301-402-1533 |
|
Grants management issues |
410-254-1853 |
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.